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We report a 74-year-old male with a previous history of coronary stenting and left 
femoro-popliteal (F-P) bypass surgery. He took rosuvastatin, ARB, and spironolactone 
other than antiplatelet (aspirin and clopidgrel) and warfarin. He admitted to our hospital one 
day after cholecystectomy because of sudden pain of the left lower extremity during the 
discontinuation of double antiplatelet and anticoagulant therapy. Enhanced computed 
tomography (CT) revealed total occlusion of the proximal portion of the F-P bypass 
anastomotic site on the common femoral artery and on the popliteal artery to the anterior 
tibial artery (Fig. 1A). Even after heparin infusion and re-introduce of antiplatelet (aspirin 
and cilostazol), his symptom did not improve. Urgent percutaneous angioplasty failed to 
recanalize the region because of recurring thrombus associated with elevated creatine 
kinase (2792 IU/L). His left ankle blood pressure was undetectable, and thermography 
revealed coldness of his left lower limbs (Fig. 1A). Consequently, LDL apheresis (LDL-A) 
using a dextran sulphate cellulose column (Liposorber LA-15, Kaneka Corp. Osaka, Japan) 
was introduced through his antecubital veins while adequately controlling his LDL 
cholesterol to <60 mg/dl. We treated 3500ml of plasma per session. Heparin was given as 
an intravenous bolus (1000 IU) at the beginning and then continuously (500 IU/h) 
injections. 
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Surprisingly, the pain diminished, paresthesia improved and he felt warmth in his 
extremity only after the first session of LDL-A. The initial levels of total cholesterol, 
triglyceride, HDL cholesterol, and LDL cholesterol were 142, 85, 67 and 58 mg/dl, 
respectively, which were decreased to 89, 28, 61 and 17 mg/dl after LDL-A respectively. 
After once a week 10 sessions of LDL-A, the serum fibrinogen level decreased 
from 390 to 335 mg/dl and D-dimer also decreased from 3.1 to 0.7 µg/ml. Thermography 
revealed an improvement of skin temperature (Fig. 1B). Moreover, enhanced CT showed 
the recanalization of proximal and distal portions of the F-P bypass anastomotic site (Fig. 
1B), suggesting the thrombolytic effect of LDL-A. As a result, the ankle blood index 
improved to 0.69 and the patient could walk without pain after LDL-A. 
LDL-A has been shown to improve clinical symptoms in patients with chronic 
peripheral artery disease (PAD)(1). The present case suffered acute thrombotic occlusion of 
his left leg accompanied by chronic PAD. After LDL-A, the thrombi completely 
disappeared with improvement in his symptoms. According to past reports(2), plasma 
constituents, including the proteins related to activation of the intrinsic coagulation pathway 
and some of the coagulation factors, are also absorbed by the dextran sulfate cellulose 
column. Another report indicated that not only cholesterol but also fibrinogen concentration, 
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which are correlated with plasma viscosity(3), was reduced during LDL-A(4). The 
combination of various factors, inactivation of the coagulation pathway, the improvement 
of hemorheology and enhanced collateral circulation might have also contributed to our 
patient’s favorable outcome. 
In conclusion, we report a case in which critical limb ischemia induced by acute 
thrombotic occlusion accompanied by chronic PAD was effectively salvaged by LDL-A. 














Enhanced computed tomography (CT) and angiography showed thrombotic occlusion of 
the common femoral artery (CFA; arrow head) and the popliteal artery (POP; arrow). 
Thermography revealed coldness of his left leg. His left ankle blood pressure could not be 
detected before LDL-A (A). Enhanced CT showed recanalization of CFA and POP 
(outlined arrow head and outlined arrow, respectively). Thermography revealed almost 
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